The University of Colorado Health Sciences Center Pharmacology Graduate Training Program is requesting annual support for nine pre-doctoral students throughout a five-year period. The Pharmacology Training Program is one of the longest funded NIGMS Pharmacology Training Programs (twenty-five plus years). This Graduate Training Program distinguishes itself by providing an environment in which students can obtain a broad-based integrative perspective of science, training in the foundation of knowledge that defines pharmacology, and sophistication in specialized, modern, research areas. The Pharmacology Training Faculty (47 members) is drawn both from within and from outside of the Department of Pharmacology, in the School of Medicine, to provide training opportunities in the areas of pharmacogenetics, neuropharmacology and addictive processes, cellular/molecular pharmacology and oncology, molecular structure and drug design, bioinformatics and computational pharmacology, as well as clinical pharmacology. The M.D. and Ph.D. preceptors in the Program are seasoned researchers and mentors with significant extramural funding. The sources of students entering the Program include direct applicants to the Program, as well as individuals who transition from umbrella programs such as the Biomedical Sciences Program and the Medical Scientist Training Program into the Pharmacology Graduate Training Program. The Pharmacology Graduate Training Program has curricular options that include the basic pharmacology track, the molecular structure track, and the bioinformatics track. These options provide a broad array of opportunities for student career development in the pharmacological sciences. The hallmarks of our Program are a strong didactic component, requirements for laboratory rotations, a strong emphasis on student presentations in seminar settings, and a wide choice of thesis research options. The Pharmacology Research Training Program has been successful in recruiting minority applicants and matriculating all of its students within a four-to-six year period. Student presentation at national meetings, publications in peer-reviewed journals, and student competitiveness for individual NRSA awards is one measure of the successful training of our students. Additionally, the retention of the graduates of our Program in academic, industry, and government positions is another measure of the success of our Program training. With a renewal for five years of funding, the Program will continue to meet the national demands for individuals, trained as pharmacologists, who are individually astute researchers, can be multi-disciplinary research team members, and also have the breadth of knowledge to plan and communicate effectively across a spectrum of technologies. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007635-29
Application #
7248779
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Preusch, Peter C
Project Start
1978-07-01
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
29
Fiscal Year
2007
Total Cost
$234,834
Indirect Cost
Name
University of Colorado Denver
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Powers, Rani K; Goodspeed, Andrew; Pielke-Lombardo, Harrison et al. (2018) GSEA-InContext: identifying novel and common patterns in expression experiments. Bioinformatics 34:i555-i564
Fitzwalter, Brent E; Towers, Christina G; Sullivan, Kelly D et al. (2018) Autophagy Inhibition Mediates Apoptosis Sensitization in Cancer Therapy by Relieving FOXO3a Turnover. Dev Cell 44:555-565.e3
Goodspeed, Andrew; Jean, Annie; Costello, James C (2018) A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer. Eur Urol :
Woolfrey, Kevin M; O'Leary, Heather; Goodell, Dayton J et al. (2018) CaMKII regulates the depalmitoylation and synaptic removal of the scaffold protein AKAP79/150 to mediate structural long-term depression. J Biol Chem 293:1551-1567
Cook, Sarah G; Bourke, Ashley M; O'Leary, Heather et al. (2018) Analysis of the CaMKII? and ? splice-variant distribution among brain regions reveals isoform-specific differences in holoenzyme formation. Sci Rep 8:5448
Schuetze, Katherine B; Stratton, Matthew S; Blakeslee, Weston W et al. (2017) Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts. J Pharmacol Exp Ther 361:140-150
Amory, J K; Ostrowski, K A; Gannon, J R et al. (2017) Isotretinoin administration improves sperm production in men with infertility from oligoasthenozoospermia: a pilot study. Andrology 5:1115-1123
Mulcahy Levy, Jean M; Zahedi, Shadi; Griesinger, Andrea M et al. (2017) Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors. Elife 6:
Huang, Weize; Nakano, Mariko; Sager, Jennifer et al. (2017) Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions. Drug Metab Dispos 45:1156-1165
Blakeslee, Weston W; Lin, Ying-Hsi; Stratton, Matthew S et al. (2017) Class I HDACs control a JIP1-dependent pathway for kinesin-microtubule binding in cardiomyocytes. J Mol Cell Cardiol 112:74-82

Showing the most recent 10 out of 70 publications